IRIDEX (IRIX) Scheduled to Post Earnings on Tuesday

IRIDEX (NASDAQ:IRIX) is scheduled to announce its earnings results after the market closes on Tuesday, November 12th. Individual interested in participating in the company’s earnings conference call can do so using this link.

IRIDEX (NASDAQ:IRIX) last announced its quarterly earnings results on Thursday, August 8th. The medical equipment provider reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.04). The business had revenue of $12.63 million during the quarter, compared to analyst estimates of $12.80 million. IRIDEX had a negative net margin of 21.84% and a negative return on equity of 134.37%. During the same period last year, the company earned ($0.17) EPS.

IRIDEX Trading Up 2.2 %

Shares of NASDAQ:IRIX opened at $1.39 on Friday. The company has a market capitalization of $22.95 million, a price-to-earnings ratio of -2.11 and a beta of 0.80. IRIDEX has a 12-month low of $1.27 and a 12-month high of $3.65. The business has a 50-day moving average price of $1.71 and a 200 day moving average price of $2.06.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on shares of IRIDEX in a research note on Saturday. They issued a “hold” rating on the stock.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.